Healwell AI Inc.
HWAIF
$1.04
$0.032.98%
| Weiss Ratings | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Good | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.30 | |||
| Price History | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.64% | |||
| 30-Day Total Return | -15.95% | |||
| 60-Day Total Return | -21.95% | |||
| 90-Day Total Return | 18.34% | |||
| Year to Date Total Return | -28.31% | |||
| 1-Year Total Return | 31.44% | |||
| 2-Year Total Return | 88.45% | |||
| 3-Year Total Return | 25.62% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -55.40% | |||
| 52-Week Low % Change | 64.68% | |||
| Price | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $2.26 | |||
| 52-Week Low Price | $0.61 | |||
| 52-Week Low Price (Date) | Mar 15, 2024 | |||
| 52-Week High Price (Date) | Jun 12, 2024 | |||
| Valuation | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 170.93M | |||
| Enterprise Value | 178.56M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.15 | |||
| Earnings Per Share Growth | -63.29% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 10.10 | |||
| Price/Book (Q) | 3.14 | |||
| Enterprise Value/Revenue (TTM) | 10.99 | |||
| Price | $1.04 | |||
| Enterprise Value/EBITDA (TTM) | -12.22 | |||
| Enterprise Value/EBIT | -9.30 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 162.67M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 4881 Yonge Street Toronto, ON M2N 5X3 | |||
| Website | www.healwell.ai | |||
| Country | Canada | |||
| Year Founded | 2012 | |||
| Profitability | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -118.16% | |||
| Profit Margin | -88.04% | |||
| Management Effectiveness | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -20.93% | |||
| Return on Equity | -- | |||
| Income Statement | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 16.24M | |||
| Total Revenue (TTM) | 16.24M | |||
| Revenue Per Share | $0.10 | |||
| Gross Profit (TTM) | 7.42M | |||
| EBITDA (TTM) | -14.61M | |||
| EBIT (TTM) | -19.19M | |||
| Net Income (TTM) | -14.30M | |||
| Net Income Avl. to Common (TTM) | -14.30M | |||
| Total Revenue Growth (Q YOY) | 723.91% | |||
| Earnings Growth (Q YOY) | -64.87% | |||
| EPS Diluted (TTM) | -0.15 | |||
| EPS Diluted Growth (Q YOY) | 55.75% | |||
| Balance Sheet | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 11.28M | |||
| Cash Per Share (Q) | $0.07 | |||
| Total Current Assets (Q) | 21.81M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 57.75M | |||
| Current Ratio (Q) | 0.965 | |||
| Book Value Per Share (Q) | $0.32 | |||
| Total Assets (Q) | 94.75M | |||
| Total Current Liabilities (Q) | 22.60M | |||
| Total Debt (Q) | 14.92M | |||
| Total Liabilities (Q) | 37.00M | |||
| Total Common Equity (Q) | 53.25M | |||
| Cash Flow | HWAIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -11.04M | |||
| Cash from Financing (TTM) | 39.09M | |||
| Net Change in Cash (TTM) | 10.51M | |||
| Levered Free Cash Flow (TTM) | -4.73M | |||
| Cash from Operations (TTM) | -17.95M | |||
